Active Motif Announces Report on Recombinant Human Covid-19 Antibodies
The SARS-CoV-2 antibodies are being sourced by diagnostic developers for applications such as lateral flow assays and ELISAs.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The SARS-CoV-2 antibodies are being sourced by diagnostic developers for applications such as lateral flow assays and ELISAs.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The model-building program is open access and can be found from the home page of Charmm-GUI, a program that simulates complex biomolecular systems.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The nucleic acid assay is for the qualitative detection of SARS-CoV-2 nucleic acids in respiratory samples from individuals who are suspected of covid-19.
Read MorePosted by Laurie Bonner | Jun 25, 2020 | Covid 19 |
The action is an effort to help protect public health from fraudulent products.
Read MorePosted by Laurie Bonner | Jun 24, 2020 | Covid 19 |
Healthcare epidemiologists report using unprecedented methods in response to the unique circumstances resulting from the covid-19 pandemic.
Read More